{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T05:03:25Z","timestamp":1789016605449,"version":"build-2803163510"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T00:00:00Z","timestamp":1596153600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T00:00:00Z","timestamp":1596153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004263","name":"FAPERGS","doi-asserted-by":"crossref","award":["16\/2551-0000517-6"],"award-info":[{"award-number":["16\/2551-0000517-6"]}],"id":[{"id":"10.13039\/501100004263","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Braz J Microbiol"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s42770-020-00348-4","type":"journal-article","created":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T11:04:02Z","timestamp":1596193442000},"page":"1691-1701","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Quinolines derivatives as promising new antifungal candidates for the treatment of candidiasis and dermatophytosis"],"prefix":"10.1007","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1950-9731","authenticated-orcid":false,"given":"Gabriella","family":"da Rosa Monte Machado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Diedrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tha\u00eds Carine","family":"Ruaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline Rigon","family":"Zimmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1rio","family":"Lettieri Teixeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu\u00eds Fl\u00e1vio","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mickael","family":"Jean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Van de Weghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saulo Fernandes","family":"de Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone Cristina","family":"Baggio Gnoatto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre Meneghello","family":"Fuentefria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,31]]},"reference":[{"key":"348_CR1","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.cub.2013.03.026","volume":"23","author":"RR Achterman","year":"2013","unstructured":"Achterman RR, White TC (2013) Dermatophytes. Curr Biol 23:551\u2013552","journal-title":"Curr Biol"},{"key":"348_CR2","doi-asserted-by":"crossref","first-page":"230","DOI":"10.4322\/2357-9730.68880","volume":"36","author":"DF Dalla Lana","year":"2016","unstructured":"Dalla Lana DF, Batista BG, Alves SH, Fuentefria AM (2016) Dermatophytosis: etiologic agents, clinical forms, therapy and new perspectives of treatment. Clin Biomed Res 36:230\u2013241","journal-title":"Clin Biomed Res"},{"key":"348_CR3","first-page":"646","volume":"6","author":"P Saxena","year":"2017","unstructured":"Saxena P, Mamta RS, Hooda M (2017) A review on superficial fungal infections: clinical symptoms and treatment. World J Pharm Pharma Sci 6:646\u2013658","journal-title":"World J Pharm Pharma Sci"},{"key":"348_CR4","doi-asserted-by":"crossref","unstructured":"Teklebirhan G, Bitew A (2015) Prevalence of dermatophytic infection and the spectrum of dermatophytes in patients attending a tertiary hospital in Addis Ababa. Ethiopia Int J Microbiol:1\u20136","DOI":"10.1155\/2015\/653419"},{"key":"348_CR5","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4103\/2229-5178.178099","volume":"7","author":"AK Sahoo","year":"2016","unstructured":"Sahoo AK, Mahajan R (2016) Management of tinea corporis, tinea cruris, and tinea pedis: a comprehensive review. Indian Dermatol Online J 7:77\u201386","journal-title":"Indian Dermatol Online J"},{"key":"348_CR6","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.biopha.2018.09.045","volume":"108","author":"X Song","year":"2018","unstructured":"Song X, Wei W, Lai K, Zhen-Dan H, Hong-Jie Z (2018) In vivo antifungal activity of dipyrithione against Trichophyton rubrum on guinea pig dermatophytosis models. Biomed Pharmacother 108:558\u2013564","journal-title":"Biomed Pharmacother"},{"key":"348_CR7","doi-asserted-by":"crossref","unstructured":"Rouzaud C, Lanternier F, Puel (2016) A primary immunodeficiencies and dermatophytosis. In: Carvalho A (ed) Immunogenetics of Fungal Diseases. Springer, pp 121\u2013133","DOI":"10.1007\/978-3-319-50842-9_5"},{"key":"348_CR8","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.riam.2014.01.003","volume":"32","author":"LDS Ramos","year":"2015","unstructured":"Ramos LDS, Barbedo LS, Braga-Silva LA, Dos Santos AL, Pinto MR, Sgarbi DB (2015) Protease and phospholipase activities of Candida spp. isolated from cutaneous candidiasis. Rev Iberoam Micol 32:122\u2013125","journal-title":"Rev Iberoam Micol"},{"key":"348_CR9","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","volume":"62","author":"PG Pappas","year":"2016","unstructured":"Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, Reboli AC, Schuster MG, Vazquez JA, Walsh TJ, Zaoutis TE Sobel JD (2016) Clinical practice guideline for the management of candidiasis: 2016 update by the infectious diseases society of America. Clin Infect Dis 62:e1\u2013e50","journal-title":"Clin Infect Dis"},{"key":"348_CR10","first-page":"1","volume":"54","author":"MA Pfaller","year":"2016","unstructured":"Pfaller MA, Castanheira M (2016) Nosocomial candidiasis: antifungal stewardship and the importance of rapid diagnosis. Med Mycol 54:1\u201322","journal-title":"Med Mycol"},{"key":"348_CR11","first-page":"1","volume":"5","author":"AM Fuentefria","year":"2016","unstructured":"Fuentefria AM, Andrade SF, Silveira GP, Kulkamp I, Pippi B, Machado MM, De Oliveira LFS, Cruz L, Frizzo C, Martins AF (2016) Caracteriza\u00e7\u00e3o do perfil de susceptibilidade a antif\u00fangicos az\u00f3licos de uma micoteca como embasamento para estrat\u00e9gias de combate \u00e0 candidemias. J Inf Control 5:1\u201311","journal-title":"J Inf Control"},{"key":"348_CR12","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1007\/s00018-015-1860-z","volume":"72","author":"EJ Polvi","year":"2015","unstructured":"Polvi EJ, Li XO, Meara TR, Leach MD, Cowen LE (2015) Opportunistic yeast pathogens: reservoirs, virulence mechanisms, and therapeutic strategies. Cell Mol Life Sci 72:2261\u20132287","journal-title":"Cell Mol Life Sci"},{"key":"348_CR13","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ijantimicag.2017.05.019","volume":"50","author":"D Farmakiotis","year":"2017","unstructured":"Farmakiotis D, Kontoyiannis DP (2017) Epidemiology of antifungal resistance in human pathogenic yeasts: current viewpoint and practical recommendations for management. Int J Antimicrob Agents 50:318\u2013324","journal-title":"Int J Antimicrob Agents"},{"key":"348_CR14","first-page":"B5288","volume":"63","author":"RH Jensen","year":"2016","unstructured":"Jensen RH (2016) Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment. Dan Med J 63:B5288","journal-title":"Dan Med J"},{"key":"348_CR15","doi-asserted-by":"crossref","first-page":"e383","DOI":"10.1016\/S1473-3099(17)30316-X","volume":"17","author":"DS Perlin","year":"2017","unstructured":"Perlin DS, Rautemaa-Richardson R, Alastruey-Izquierdo A (2017) The global problem of antifungal resistance: prevalence, mechanisms, and management. Lancet Infect Dis 17:e383\u2013ee39","journal-title":"Lancet Infect Dis"},{"key":"348_CR16","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2147\/IDR.S124918","volume":"10","author":"NP Wiederhold","year":"2017","unstructured":"Wiederhold NP (2017) Antifungal resistance: current trends and future strategies to combat. Infect Drug Resist 10:249\u2013259","journal-title":"Infect Drug Resist"},{"key":"348_CR17","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1007\/s10096-018-3317-4","volume":"37","author":"Z Salehi","year":"2018","unstructured":"Salehi Z, Shams-Ghahfarokhi M, Razzaghi-Abyaneh M (2018) Antifungal drug susceptibility profile of clinically important dermatophytes and determination of point mutations in terbinafine-resistant isolates. Eur J Clin Microbiol Infect Dis 37:1841\u20131846","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"348_CR18","doi-asserted-by":"crossref","first-page":"524","DOI":"10.4103\/0253-7613.117751","volume":"45","author":"H Okuyan","year":"2013","unstructured":"Okuyan H, Altin C (2013) Heart failure induced by itraconazole. Indian J Pharm 45:524\u2013535","journal-title":"Indian J Pharm"},{"key":"348_CR19","first-page":"112","volume":"9","author":"J Liu","year":"2014","unstructured":"Liu J, Warshaw EM (2014) Allergic contact dermatitis from ketoconazole. Cutis. 9:112\u2013114","journal-title":"Cutis."},{"key":"348_CR20","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1080\/14787210.2016.1199272","volume":"14","author":"FP Tverdek","year":"2016","unstructured":"Tverdek FP, Kofteridis D, Kontoyiannis DP (2016) Antifungal agents and liver toxicity: a complex interaction. Expert Rev Anti-Infect Ther 14:765\u2013777","journal-title":"Expert Rev Anti-Infect Ther"},{"key":"348_CR21","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jiac.2017.02.008","volume":"23","author":"Y Shibata","year":"2017","unstructured":"Shibata Y, Hagihara M, Kato H, Kawasumi N, Hirai J, Nishiyama N, Asai N, Koizumi Y, Yamagishi Y, Matsuura K, Mikamo H (2017) Caspofungin versus micafungin in the incidence of hepatotoxicity in patients with normal to moderate liver failure. J Infect Chemother 23:349\u2013353","journal-title":"J Infect Chemother"},{"key":"348_CR22","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.biopha.2014.10.007","volume":"68","author":"RS Keri","year":"2014","unstructured":"Keri RS, Patil SA (2014) Quinoline: a promising antitubercular target. Biomed Pharmacother 68:1161\u20131175","journal-title":"Biomed Pharmacother"},{"key":"348_CR23","first-page":"00036","volume":"2","author":"KMA El-Gamal","year":"2015","unstructured":"El-Gamal KMA, Sherbiny FF, El-Morsi AM, Abu-El-khair HE, Eissa IH, El-Sebaei MM (2015) Design, synthesis and antimicrobial evaluation of some novel quinoline derivatives. Pharm Pharmacol Int J 2:00036","journal-title":"Pharm Pharmacol Int J"},{"key":"348_CR24","doi-asserted-by":"crossref","first-page":"53","DOI":"10.32712\/2446-4775.2010.119","volume":"5","author":"AC Pinheiro","year":"2010","unstructured":"Pinheiro AC, Bispo MLF, Souza MVN (2010) Importance of quinoline nucleus and its derivatives in drug discovery. Rer Fitos 5:53\u201363","journal-title":"Rer Fitos"},{"key":"348_CR25","doi-asserted-by":"crossref","first-page":"947","DOI":"10.4155\/fmc.15.34","volume":"7","author":"PY Chung","year":"2015","unstructured":"Chung PY, Bian ZX, Pun HY, Dessy C, Chan AS, Chui CH, Tang JC, Lam KH (2015) Recent advances in research of natural and synthetic bioactive quinolines. Future Med Chem 7:947\u2013967","journal-title":"Future Med Chem"},{"key":"348_CR26","first-page":"115","volume":"42","author":"R Parhizgar","year":"2017","unstructured":"Parhizgar R, Tahghigh A (2017) Introducing new antimalarial analogues of chloroquine and amodiaquine: a narrative review. Iran J Med Sci 42:115 Corpus ID: 17353632","journal-title":"Iran J Med Sci"},{"key":"348_CR27","doi-asserted-by":"crossref","first-page":"104762","DOI":"10.1016\/j.antiviral.2020.104762","volume":"177","author":"F Touret","year":"2020","unstructured":"Touret F, Lamballerie L (2020) Of chloroquine and COVID-19. Antivir Res 177:104762","journal-title":"Antivir Res"},{"key":"348_CR28","doi-asserted-by":"publisher","unstructured":"Colson P, Rolain JM, Lagier JC, Brouqui P, Raoult D (2020) Chloroquine and hydroxychloroquine as available weapons to fight COVID-19. Int J Antimicrob Agents. https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.105932","DOI":"10.1016\/j.ijantimicag.2020.105932"},{"key":"348_CR29","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.ejmech.2014.07.044","volume":"97","author":"O Afzal","year":"2015","unstructured":"Afzal O, Kumar S, Haider MR, Ali MR, Kumar R, Jaggi M, Bawa S (2015) A review on anticancer potential of bioactive heterocycle quinoline. Eur J Med Chem 97:871\u2013910","journal-title":"Eur J Med Chem"},{"key":"348_CR30","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3109\/14756366.2014.930454","volume":"30","author":"S Singh","year":"2015","unstructured":"Singh S, Kaur G, Mangla V, Gupta MK (2015) Quinoline and quinolones: promising scaffolds for future antimycobacterial agents. J Enzyme Inhib Med Chem 30:492\u2013504","journal-title":"J Enzyme Inhib Med Chem"},{"key":"348_CR31","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1007\/s00044-015-1323-y","volume":"24","author":"X Wen","year":"2015","unstructured":"Wen X, Wang S, Liu D, Gong G, Quan Z (2015) Synthesis and evaluation of the anti-inflammatory activity of quinoline derivatives. Med Chem Res 24:2591\u20132603","journal-title":"Med Chem Res"},{"key":"348_CR32","first-page":"1007","volume":"2","author":"JJ Casal","year":"2017","unstructured":"Casal JJ, As\u00eds SE (2017) Natural and synthetic quinoline derivatives as antituberculosis agentes. Austin Tuberc Res Treat 2:1007","journal-title":"Austin Tuberc Res Treat"},{"key":"348_CR33","first-page":"135","volume":"35","author":"D Kadri","year":"2013","unstructured":"Kadri D, Crater AK, Lee H, Solomon VR, Ananvoranich S (2013) The potential of quinoline derivatives for the treatment of Toxoplasma gondii infection. Exp Parasitol 35:135\u2013144","journal-title":"Exp Parasitol"},{"key":"348_CR34","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.arabjc.2011.08.007","volume":"7","author":"NC Desai","year":"2014","unstructured":"Desai NC, Dodiya AM (2014) Synthesis, characterization and antimicrobial screening of quinoline based quinazolinone-4-thiazolidinone heterocycles. Arab J Chem 7:906\u2013913","journal-title":"Arab J Chem"},{"key":"348_CR35","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.bmc.2018.05.031","volume":"26","author":"P Teng","year":"2018","unstructured":"Teng P, Li C, Peng Z, Vanderschouw AM, Nimmagadda A, Su M, Li Y, Sun X, Cai J (2018) Facilely accessible quinoline derivatives as potent antibacterial agents. Bioorg Med Chem 26:3573\u20133579","journal-title":"Bioorg Med Chem"},{"key":"348_CR36","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.ejmech.2010.12.002","volume":"46","author":"S Kumar","year":"2011","unstructured":"Kumar S, Bawa S, Drabu S, Gupta H, Machwal L, Kumar R (2011) Synthesis, antidepressant and antifungal evaluation of novel 2-chloro-8-methylquinoline amine derivatives. Eur J Med Chem 46:670\u2013675","journal-title":"Eur J Med Chem"},{"key":"348_CR37","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.bmc.2016.12.023","volume":"25","author":"NA Liberato","year":"2017","unstructured":"Liberato NA, Sim\u00f5es JB, Silva SP, Da Silva CJ, Modolo LV, De F\u00e1tima A, Fernandes AS (2017) Quinolines: microwave-assisted synthesis and their antifungal, anticancer and radical scavenger properties. Bioorg Med Chem 25:1153\u20131162","journal-title":"Bioorg Med Chem"},{"key":"348_CR38","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.ejmech.2017.10.046","volume":"143","author":"MF El Shehry","year":"2018","unstructured":"El Shehry MF, Ghorab MM, Abbas SY, Fayed EA, Shedid SA, Ammar YH (2018) Quinoline derivatives bearing pyrazole moiety: synthesis and biological evaluation as possible antibacterial and antifungal agents. Eur J Med Chem 143:1463\u20131473","journal-title":"Eur J Med Chem"},{"key":"348_CR39","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0040-4020(02)01587-9","volume":"59","author":"BC Ranu","year":"2003","unstructured":"Ranu BC, Hajra A, Dey SS, Jana U (2003) Efficient microwave-assisted synthesis of quinolines and dihydroquinolines under solvent-free conditions. Tetrahedron. 59:813\u2013819","journal-title":"Tetrahedron."},{"key":"348_CR40","first-page":"399","volume":"58","author":"V Zoete","year":"2016","unstructured":"Zoete V, Daina A, Bovigny C, Michielin O (2016) SwissSimilarity: a web tool for low to ultra-high-throughput ligand-based virtual screening. J Chem Inf Model 58:399\u20131404","journal-title":"J Chem Inf Model"},{"key":"348_CR41","first-page":"427","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina A, Michielin O, Zoete V (2017) SwissADME: a free web tool to evaluate pharmacokinetics, druglikeness and medicinal chemistry friendliness of small molecules. J Chem Inf Model 7:427\u2013517","journal-title":"J Chem Inf Model"},{"key":"348_CR42","first-page":"935","volume":"14","author":"Z Zaheer","year":"2015","unstructured":"Zaheer Z, Khan FAK, Sangshetti JN, Patil RH (2015) Efficient one-pot synthesis, molecular docking and in silico ADME prediction of bis-(4-hydroxycoumarin-3-yl) methane derivatives as antileishmanial agents. EXCLI J 14:935\u2013947","journal-title":"EXCLI J"},{"key":"348_CR43","unstructured":"Clinical and Laboratory Standards Institute (CLSI) (2008) Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; Approved Standard, 2nd edn. CLSI Document M38-A2. Clinical Laboratory Standards Institute, Wayne"},{"key":"348_CR44","unstructured":"Clinical and Laboratory Standards Institute (CLSI) (2008) Reference method for broth dilution antifungal susceptibility testing of yeasts; Approved Standard, 3rd edn. CLSI Document M27\u2013A3. Clinical Laboratory Standards Institute, Wayne"},{"key":"348_CR45","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1476-0711-10-3","volume":"10","author":"K Ishida","year":"2011","unstructured":"Ishida K, Rodrigues JCF, Cammerer S, Urbina JA, Gilbert I, De Souza W, Rozental S (2011) Synthetic arylquinuclidine derivatives exhibit antifungal activity against Candida albicans, Candida tropicalis and Candida parapsilopsis. Ann Clin Microbiol Antimicrob 10:3","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"348_CR46","volume-title":"The hen\u2019s egg test\u2013chorioallantoic membrane (HET-CAM) test method","author":"Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVMA)","year":"2010","unstructured":"Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVMA) (2010) The hen\u2019s egg test\u2013chorioallantoic membrane (HET-CAM) test method. National Toxicology Program, Research Triangle Park"},{"key":"348_CR47","unstructured":"Brasil (2013) Minist\u00e9rio da agricultura. Instru\u00e7\u00e3o Normativa n\u00b0 3\/2000 de 17 de janeiro de 2000. Aprova regulamento t\u00e9cnico de m\u00e9todos de insensibiliza\u00e7\u00e3o para abate humanit\u00e1rio de animais de a\u00e7ougue"},{"key":"348_CR48","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0027-5107(00)00065-8","volume":"455","author":"M Fenech","year":"2000","unstructured":"Fenech M (2000) The in vitro micronucleus technique. Mutat Res 455:81\u201395","journal-title":"Mutat Res"},{"key":"348_CR49","doi-asserted-by":"crossref","first-page":"09","DOI":"10.1016\/0165-1161(75)90058-8","volume":"31","author":"W Schmid","year":"1975","unstructured":"Schmid W (1975) The micronucleus test. Mutat Res 31:09\u201315","journal-title":"Mutat Res"},{"key":"348_CR50","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.mimet.2015.10.004","volume":"118","author":"PC De Souza","year":"2015","unstructured":"De Souza PC, Morey AT, Castanheira GM, Bocate KP, Panagio LA, Ito FA, Almeida RS (2015) Tenebrio molitor (Coleoptera: Tenebrionidae) as an alternative host to study fungal infections. J Microbiol Methods 118:182\u2013186","journal-title":"J Microbiol Methods"},{"key":"348_CR51","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.2174\/092986711795328382","volume":"18","author":"VR Solomon","year":"2011","unstructured":"Solomon VR, Lee H (2011) Quinoline as a privileged scaffold in cancer drug discovery. Curr Med Chem 18:1488\u20131508","journal-title":"Curr Med Chem"},{"issue":"93","key":"348_CR52","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.ejmech.2015.02.034","volume":"93","author":"SR Patel","year":"2015","unstructured":"Patel SR, Gangwal R, Sangamwar AT, Jain R (2015) Synthesis, biological evaluation and 3D QSAR study of 2,4-disubstituted quinolines as anti-tuberculosis agents. Eur J Med Chem 93(93):511\u2013522","journal-title":"Eur J Med Chem"},{"key":"348_CR53","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.ejmech.2009.10.050","volume":"45","author":"CL Yang","year":"2010","unstructured":"Yang CL, Tseng CH, Chen YL, Lu CM, Kao CL, Wu MH, Tzeng CC (2010) Identification of benzofuro[2,3-b]quinoline derivatives as a new class of antituberculosis agents. Eur J Med Chem 45:602\u2013607","journal-title":"Eur J Med Chem"},{"key":"348_CR54","doi-asserted-by":"crossref","first-page":"680","DOI":"10.2174\/157018012801319544","volume":"9","author":"VV Kouznetsov","year":"2012","unstructured":"Kouznetsov VV, Ru\u00edza FAJ, M\u00e9ndeza LYV, Gupta MP (2012) Simple C-2-substituted quinolines and their anticancer activity. Lett Drug Des Discov 9:680\u2013686","journal-title":"Lett Drug Des Discov"},{"key":"348_CR55","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.phytol.2016.07.007","volume":"17","author":"K Supong","year":"2016","unstructured":"Supong K, Thawai C, Supothina S, Auncharoen P, Pittayakhajonwut P (2016) Antimicrobial and anti-oxidant activities of quinoline alkaloids from Pseudomonas aeruginosa BCC76810. Phytochem Lett 17:100\u2013106","journal-title":"Phytochem Lett"},{"key":"348_CR56","doi-asserted-by":"crossref","first-page":"805","DOI":"10.4065\/mcp.2011.0247","volume":"86","author":"RE Lewis","year":"2011","unstructured":"Lewis RE (2011) Current concepts in antifungal pharmacology. Mayo Clin Proc 86:805\u2013817","journal-title":"Mayo Clin Proc"},{"key":"348_CR57","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/jac\/dkt508","volume":"69","author":"HR Ashbee","year":"2014","unstructured":"Ashbee HR, Barnes RA, Johnson EM, Richardson MD, Gorton R, Hope WW (2014) Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology. J Antimicrob Chemother 69:1162\u20131176","journal-title":"J Antimicrob Chemother"},{"key":"348_CR58","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jceh.2014.03.040","volume":"4","author":"NS Choudhary","year":"2014","unstructured":"Choudhary NS, Kotecha H, Saraf N, Gautam D, Saigal S (2014) Terbinafine induced liver injury: a case report. J Clin Exp Hepatol 4:264\u2013265","journal-title":"J Clin Exp Hepatol"},{"key":"348_CR59","doi-asserted-by":"crossref","unstructured":"Folk A, Cotoraci C, Balta C, Suciu M, Herman H, Boldura OA, Dinescu S, Paiusan L, Ardelean A, Hermenean A (2016) Evaluation of hepatotoxicity with treatment doses of flucytosine and amphotericin-B for invasive fungal infections. Biomed Res Int:2016","DOI":"10.1155\/2016\/5398730"},{"key":"348_CR60","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.mrgentox.2015.01.003","volume":"780-781","author":"F Uno","year":"2015","unstructured":"Uno F, Tanaka J, Ueda M, Nagai M, Fukumuro M, Natsume M, Oba M, Akahori A, Masumori S, Takami S, Wako Y, Kawasako K, Kougo Y, Ohyama W, Narumi K, Fujiishi Y, Okada E, Hayashi M (2015) Repeated-dose liver and gastrointestinal tract micronucleus assays for quinoline in rats. Mutat Res Genet Toxicol Environ Mutagen 780-781:51\u201355","journal-title":"Mutat Res Genet Toxicol Environ Mutagen"},{"key":"348_CR61","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1248\/jhs.53.325","volume":"53","author":"T Suzuki","year":"2007","unstructured":"Suzuki T, Takeshita K, Saeki K, Kadoi M, Hayashi M, Sofuni T (2007) Clastogenicity of quinoline and monofluorinated quinolines in chinese hamster lung cells. J Health Sci 53:325\u2013328","journal-title":"J Health Sci"},{"key":"348_CR62","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.mrgentox.2007.08.012","volume":"649","author":"D Yuzbasioglu","year":"2008","unstructured":"Yuzbasioglu D, Unal F, Y\u0131lmaz S, Aksoy H, Celik M (2008) Genotoxicity testing of fluconazole in vivo and in vitro. Mutat Res 649:155\u2013160","journal-title":"Mutat Res"},{"key":"348_CR63","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0165-1218(94)90001-9","volume":"322","author":"P Kolachana","year":"1994","unstructured":"Kolachana P, Smith MT (1994) Induction of kinetochore-positive micronuclei in human lymphocytes by the anti-fungal drug griseofulvin. Mutat Res 322:151\u2013159","journal-title":"Mutat Res"},{"key":"348_CR64","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jsps.2013.11.002","volume":"23","author":"SK Doke","year":"2015","unstructured":"Doke SK, Dhawale SC (2015) Alternatives to animal testing: a review. Saudi Pharm J 23:223\u2013229","journal-title":"Saudi Pharm J"},{"key":"348_CR65","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.mjafi.2013.01.007","volume":"69","author":"R Verma","year":"2013","unstructured":"Verma R, Vasudevan B, Pragasam V (2013) Severe cutaneous adverse drug reactions. Med J Armed Forces India 69:375\u2013383","journal-title":"Med J Armed Forces India"},{"key":"348_CR66","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3109\/10837450.2013.860544","volume":"20","author":"VA Pinheiro","year":"2013","unstructured":"Pinheiro VA, Serikaku D, Baby AR, Velasco MVR, Kaneko TM, Consiglieri VO (2013) Development of ciclopirox olamine topical formulations: evaluation of drug release, penetration and cutaneous retention. Pharm Dev Technol 20:197\u2013203","journal-title":"Pharm Dev Technol"}],"container-title":["Brazilian Journal of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42770-020-00348-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s42770-020-00348-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42770-020-00348-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T18:21:07Z","timestamp":1744136467000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s42770-020-00348-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,31]]},"references-count":66,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["348"],"URL":"https:\/\/doi.org\/10.1007\/s42770-020-00348-4","relation":{},"ISSN":["1517-8382","1678-4405"],"issn-type":[{"value":"1517-8382","type":"print"},{"value":"1678-4405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,31]]},"assertion":[{"value":"7 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}